Clinical Trial Update: Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated Opioid Growth Factor for unresectable hepatocellular carcinoma and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Opioid Growth Factor

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Hepatocellular Cancer | Phase 1 | Status: COMPLETED